51
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Cellular Pharmacology of P-ethoxy Antisense Oligonucleotides Targeted to Bcl-2 in a Follicular Lymphoma Cell Line

, , , , , & show all
Pages 1979-1985 | Published online: 01 Jul 2009

References

  • Reed, J.C. (1997) "Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies", Seminars in Hematology 34, 9–19.
  • Lin, Y., Lu, L. and Hu, J. (1999) "Inhibition of Bcl-2 expression in HL60 cells by incubation with antisense phosphorothioate oligodeoxynucleotides", Chung-Hua i Hsueh i Chuan Hsueh Tsa Chih 16, 12–15.
  • Raynaud, F., Orr, R., Goddard, P., Lacely, H., Lancashire, H., Judson, I., Beck, T., Bryan, B. and Cotter, F. (1997) "Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to Bcl-2, after intravenous administration or continuous subcutaneous infusion to mice", Journal of Pharmacology and Experimental Therapeutics 281, 420–427.
  • Waters, J.S. (2000) "Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non- Hodgkin's lymphoma [see comments]", Journal of Clinical Oncology 18, 1812–1823.
  • Stein, C.A. and Cheng, Y.C. (1993) "Antisense oligonucleotides as therapeutic agents�is the bullet really magical?", Science 261, 1004–1012.
  • Matteucci, M. (1997) "Oligonucleotide analogues: an overview", Ciba Foundation Symposium 209, 5–14, Discussion 14–8.
  • Tari, A. and Lopez-Berestein, G. (1997) "Oligonucleotide therapy for hematological malignancies", Journal of Liposomal Research 7, 19–30.
  • Tormo, M., Tari, A.M., McDonnell, T.J., Cabanillas, F., Garcia- Conde, J. and Lopez-Berestein, G. (1998) "Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation", Leukemia and Lymphoma 30, 367–379.
  • Campbell, J.M., Bacon, T.A. and Wickstrom, E. (1990) "Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid", Journal of Biochemical and Biophysical Methods 20, 259–267.
  • Ollikainen, H., Lappalainen, K., Jaaskelainen, I., Syrjanen, S. and Pulkki, K. (1996) "Liposomal targeting of Bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines", Leukemia and Lymphoma 24, 165–174.
  • Zamecnik, P.C. and Stephenson, M.L. (1978) "Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide", Proceedings of the National Academy of Sciences of the United States of America 75, 280–284.
  • Blake, K.R., Murakami, A. and Miller, P.S. (1985) "Inhibition of rabbit globin mRNA translation by sequence-specific oligodeoxyribonucleotides", Biochemistry 24, 6132–6138.
  • Cazenave, C., Loreau, N., Thuong, N.T., Toulme, J.J. and Helene, C. (1987) "Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents", Nucleic Acids Research 15, 4717–4736.
  • Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J.S. and Broder, S. (1987) "Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus", Proceedings of the National Academy of Sciences of the United States of America 84, 7706–7710.
  • Miller, P., Agris, C., Aurelian, A., Blake, K., Murakami, M., Reddy, P., Spitz, S. and Ts'o, P. (1985) "Control of ribonucleic acid function by oligonucleoside methylphosphonates", Biochimie 67, 769–776.
  • Morvan, F., Rayner, B., Imbach, J.L., Chang, D.K. and Lown, J.W. (1987) "Alpha-DNA-III. Characterization by high field 1H-NMR, anti-parallel self-recognition and conformation of the unnatural hexadeoxyribonucleotides alpha-[d(CpApTpGpCpG)] and alpha- [d(CpGpCpApTpG)]. Alpha-oligodeoxynucleotides as potential cellular probes for gene control", Nucleic Acids Research 15, 4241–4255.
  • Beham, A., Marin, M., Fernandez, A., Hermann, J., Brisbay, S., Tari, A., Lopez-Berestein, G., Lozano, G., Sarkiss, M. and McDonnell, T. (1997) "Bcl-2 inhibits p53 nuclear import following DNA damage", Oncogene 15, 2767–2772.
  • Gutierrez-Puente, Y., Tari, A.M., Stephens, C., Rosenblum, M., Guerra, R.T. and Lopez-Berestein, G. (1999) "Safety, pharmacokinetics, and tissue distribution of liposomal P-ethoxy antisense oligonucleotides targeted to Bcl-2", Journal of Pharmacology and Experimental Therapeutics 291, 865–869.
  • Tari, A., Stephens, C., Rosenblum, M. and Lopez-Berestein, G. (1998) "Pharmacokinetics, tissue distribution and safety of P-ethoxy oligonucleotides incorporated in liposomes", Journal of Liposome Research 8, 251–264.
  • Zar, J.H. (1999) Biostatistical Analysis, 4th Ed. (Prentice Hall, New Jersey).
  • Tari, A., Andreeff, M., Kleine, H. and Lopez-Berestein, G. (1996) "Cellular uptake and localization of liposomal-methylphosphonate oligodeoxynucleotides", Journal of Molecular Medicine 74, 623–628.
  • Krieg, A., Gmelig-Meyling, F., Gourley, M., Kisch, W., Chrisey, L. and Steinberg, A. (1991) "Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible", Antisense Research and Development 1, 161–171.
  • White, P., Fogarty, R., McKean, S., Venables, D., Werther, G. and Wraight, C. (1999) "Oligonucleotide uptake in cultured keratinocytes: influence of confluence, cationic liposomes, and keratinocyte cell type", The Journal of Investigative Dermatology 112, 699–705.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.